TotalMarketCap

PDS Biotechnology

PDSBNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$123.906 M

$1.18 -9.23%

Close of 6 Nov 2026

As of 6 Nov 2026, PDS Biotechnology (PDSB) has a market capitalization of $123.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$34.5M

Loss-making

Shares outstanding

55,971,338

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #274Cue BiopharmaCUE$128.9M
  2. #275Yarrow BioscienceYARW$126.1M
  3. #276PDS BiotechnologyPDSB$123.9M
  4. #277Spruce BiosciencesSPRB$122.4M
  5. #278Akebia TherapeuticsAKBA$121.3M

What if PDS Biotechnology were worth as much as…

Open the what-if tool →

Gold $28.2T

$268,908.70

Per share 227,889× higher

Bitcoin $1.53T

$14,550.18

Per share 12,331× higher

Apple $5.02T

$47,766.89

Per share 40,480× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for PDS Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.